Back to search
Migraine Aura
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Migraine Aura trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Migraine Aura trials you may qualify forThe purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of ag…
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and ad…
The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migra…
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatm…
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatm…
This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive…
The purpose of this study is to evaluate safety and effectiveness of NURTEC® ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine w…
The aim is to compare the effectiveness of a behavioral treatment, the Acceptance and Commitment Therapy, provided as an add-on to the prophylactic treatment (t…
This is a prospective, double-blind, sham-controlled, randomized, decentralized trial. This study aims to assess the safety and efficacy of the Mi-Helper transn…